THE SPECTRUM OF IMMUNOHISTOCHEMICAL STAINING OF SMALL-CELL LUNG-CARCINOMA IN SPECIMENS FROM TRANSBRONCHIAL AND OPEN-LUNG BIOPSIES

被引:113
作者
GUINEE, DG
FISHBACK, NF
KOSS, MN
ABBONDANZO, SL
TRAVIS, WD
机构
[1] ARMED FORCES INST PATHOL, DEPT PULM & MEDIASTINAL PATHOL, WASHINGTON, DC 20306 USA
[2] ARMED FORCES INST PATHOL, DIV IMMUNOPATHOL, WASHINGTON, DC 20306 USA
关键词
BER-EP4; BOMBESIN; CARCINOEMBRYONIC ANTIGEN; CHROMOGRANIN A; IMMUNOHISTOCHEMISTRY; KERATIN; NEURON-SPECIFIC ENOLASE; LEU-7; SMALL-CELL LUNG CARCINOMA;
D O I
10.1093/ajcp/102.4.406
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Immunohistochemistry is increasingly used as an aid in the diagnosis of small-cell lung carcinoma (SCLC). Previous studies have investigated immunohistochemical staining of SCLC with small numbers of antibodies, but few have examined large series with a broad panel of antibodies. For this reason, the authors examined the distribution and intensity of staining of 20 open-lung biopsy (OLB) and 21 transbronchial biopsy (TBB) specimens of SCLC with a panel of epithelial, neuroendocrine, and hormonal markers. Small-cell lung carcinoma stained most frequently with epithelial markers, followed by neuroendocrine and hormonal markers. Similar percentages of OLB and TBB specimens stained for keratin (100% each) and epithelial membrane antigen (100% and 95%, respectively). Unexpectedly, BER-EP4 stained 100% of OLB specimens. Chromogranin A was the most frequent neuroendocrine marker in OLB and TBB specimens (60% and 47%, respectively) followed by neuron-specific enolase (60% and 33%), Leu-7 (40% and 24%), and synaptophysin (5% and 19%). No neuroendocrine immunohistochemical reactivity was found in 24% of TBB specimens and 20% of OLB specimens. Bombesin was the most sensitive hormonal marker (45% of OLB specimens). These results show that keratin, epithelial membrane antigen, and BER-EP4 are reliable epithelial markers for SCLC in both TBB and OLB specimens. In addition, negative staining for neuroendocrine markers, because it can occur in as many as 25% of cases, should not deter the diagnosis of SCLC.
引用
收藏
页码:406 / 414
页数:9
相关论文
共 72 条
[1]  
ABO T, 1981, J IMMUNOL, V127, P1024
[2]  
AZZOPARDI JG, 1968, CANCER-AM CANCER SOC, V22, P274, DOI 10.1002/1097-0142(196808)22:2<274::AID-CNCR2820220204>3.0.CO
[3]  
2-W
[4]  
BLOBEL GA, 1985, LAB INVEST, V52, P39
[5]   DIFFERENTIAL DIAGNOSTIC PATTERNS OF LUNG NEUROENDOCRINE TUMORS - A CLINICOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL STUDY OF 122 CASES [J].
BONATO, M ;
CERATI, M ;
PAGANI, A ;
PAPOTTI, M ;
BOSI, F ;
BUSSOLATI, G ;
CAPELLA, C .
VIRCHOWS ARCHIV A-PATHOLOGICAL ANATOMY AND HISTOPATHOLOGY, 1992, 420 (03) :201-211
[6]   CANCER STATISTICS, 1993 [J].
BORING, CC ;
SQUIRES, TS ;
TONG, T .
CA-A CANCER JOURNAL FOR CLINICIANS, 1993, 43 (01) :7-26
[7]  
BOSTWICK DG, 1984, AM J PATHOL, V117, P195
[8]   SYNAPTOPHYSIN IMMUNOREACTIVITY AND SMALL CLEAR VESICLES IN NEURO-ENDOCRINE CELLS AND RELATED TUMORS [J].
BUFFA, R ;
RINDI, G ;
SESSA, F ;
GINI, A ;
CAPELLA, C ;
JAHN, R ;
NAVONE, F ;
DECAMILLI, P ;
SOLCIA, E .
MOLECULAR AND CELLULAR PROBES, 1987, 1 (04) :367-381
[9]  
BUNN PA, 1985, BLOOD, V65, P764
[10]  
CLEMENTS D, 1985, LANCET, V1, P874